Compare StocksABBV vs IEX

AbbVie Inc. (ABBV) vs IDEX Corporation (IEX): Which Is the Better Buy in 2026?

As of 2026-09-17, ABBV is overvalued at $262, with a DCF intrinsic value of $184 and a margin of safety of -43%. IEX is overvalued at $223, with an intrinsic value of $180 and a margin of safety of -24%. Of the two, IEX has the wider margin of safety.

ABBV
AbbVie Inc.
$262.50
VS
IEX
IDEX Corporation
$222.64

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
IEX
  • IDEX Corporation scores 84/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Altman Z-Score of 4.68 indicates very low bankruptcy risk — the company is firmly in the safe zone.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
IEX

    Key Valuation Metrics

    Learn more →
    ABBV
    IEX
    Valuation
    $16.87B
    Free Cash Flow
    $555.61M
    3.64%
    FCF Yield
    3.39%
    74.15
    Trailing P/E
    31.99
    16.14
    Forward P/E
    23.13
    Quality & Moat
    28.73%
    ROIC
    10.66%
    N/A
    ROE
    12.96%
    72.79%
    Gross Margin
    44.73%
    0.54
    PEG Ratio
    1.68
    Balance Sheet Safety
    N/A
    Net Debt / Equity
    0.32
    N/A
    Interest Coverage
    N/A
    2.09
    Net Debt / EBITDA
    1.31
    2.64%
    Dividend Yield
    1.32%
    ABBV: 7Ties: 1IEX: 2
    ABBVIEX

    Historical Fundamentals

    Learn more →
    ABBV

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    IEX

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    ABBV
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-19.85B
    Δ Market Cap
    +$118.02B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    IEX
    $-4.09
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $975.7M
    Δ Market Cap
    $-3.99B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    ABBV
    42.7% Overvalued
    Price is 42.7% above estimated fair value
    Current Price: $262.50
    Fair Value: $183.97
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    IEX
    23.7% Overvalued
    Price is 23.7% above estimated fair value
    Current Price: $222.64
    Fair Value: $179.94
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    ABBV

    What growth rate is the market pricing in at $262?

    +19.5%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +13.8%

    The market implies +19.5% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +13.8%, reflecting heavy growth investment.

    IEX

    What growth rate is the market pricing in at $223?

    +12.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +14.0%

    The market implies +12.4% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +14.0%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    ABBV
    82/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    IEX
    84/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Margin Stability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

    Forensic Accounting

    Learn more →
    ABBV
    -2.86
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    IEX
    -2.53
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    ABBV
    Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
    No. of Institutional Holders5,262
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    IEX
    Insiders 0.2%Institutions 105.4%
    No. of Institutional Holders1,015
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    ABBV
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    IEX
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $101,647
    CHRISTENSON CARL R
    Director
    $101,647
    @ $169.41 · 2025-11-05
    HELMKAMP KATRINA L.
    Director
    $399,026
    @ $159.61 · 2025-08-07
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    ABBV
    0
    Sells (3M)
    0
    Sells (12M)
    No open market insider sales found.
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    IEX
    1
    Sells (3M)
    2
    Sells (12M)
    Total value (12M): $3.40M
    ANDERSON LISA M
    General Counsel
    $91,859
    @ $238.59 · 2026-08-12
    ASHLEMAN ERIC D
    Chief Executive Officer
    $3.31M
    @ $215.22 · 2026-05-11
    MAHENDRA AKHIL
    Chief Financial Officer
    $45,222
    @ $180.89 · 2025-06-05
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    ABBV
    FearGreed
    😏Greed(68/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    IEX
    FearGreed
    😐Neutral(56/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    ABBV
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (68)
    IEX
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
    View ABBV Full AnalysisView IEX Full Analysis

    Frequently Asked Questions: ABBV vs IEX

    Is AbbVie Inc. or IDEX Corporation more undervalued in 2026?

    Based on our discounted cash flow model, IEX trades at a -23.7% margin of safety (intrinsic value $180 vs. price $223), compared to ABBV's -42.7% margin of safety (intrinsic $184 vs. $262).

    Which stock has a wider economic moat, AbbVie Inc. or IDEX Corporation?

    IEX scores 84/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is AbbVie Inc. in financial distress?

    ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. IEX scores 4.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which company has better free cash flow, AbbVie Inc. or IDEX Corporation?

    AbbVie Inc. (ABBV) generates a 3.6% free cash flow yield, compared to IDEX Corporation's 3.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, AbbVie Inc. or IDEX Corporation?

    ABBV earns 28.7% ROIC versus IEX's 10.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, AbbVie Inc.'s or IDEX Corporation's?

    IEX's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). IEX has raised its dividend for 3 consecutive years.

    ABBV vs IEX: Which Is the Better Buy in 2026? | SafetyMargin.io